HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xian Wang Selected Research

2-cresolphthalexon

12/2016[Secondary hyperuricemia in chronic renal failure promotes vascular calcification in rats].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xian Wang Research Topics

Disease

105Neoplasms (Cancer)
09/2022 - 07/2007
30Atherosclerosis
01/2022 - 03/2002
28Inflammation (Inflammations)
07/2022 - 10/2004
28Breast Neoplasms (Breast Cancer)
01/2022 - 01/2012
25Hyperhomocysteinemia
11/2022 - 11/2004
20Stomach Neoplasms (Stomach Cancer)
05/2022 - 01/2009
18Carcinogenesis
10/2021 - 07/2007
17Cardiovascular Diseases (Cardiovascular Disease)
03/2022 - 08/2003
14Insulin Resistance
02/2022 - 05/2005
12Vascular Calcification
01/2019 - 07/2008
10Hypertension (High Blood Pressure)
12/2021 - 08/2006
9Obesity
02/2022 - 05/2007
9Myocardial Infarction
01/2021 - 11/2004
9Infections
01/2020 - 04/2004
8Pain (Aches)
08/2022 - 08/2005
8Wounds and Injuries (Trauma)
05/2022 - 05/2005
8Hepatocellular Carcinoma (Hepatoma)
01/2022 - 08/2008
8Neoplasm Metastasis (Metastasis)
01/2021 - 01/2012
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2022 - 01/2011
7Lung Neoplasms (Lung Cancer)
07/2022 - 01/2011
7Abdominal Aortic Aneurysm
03/2022 - 10/2012
7Type 2 Diabetes Mellitus (MODY)
04/2021 - 05/2005
7Coronary Artery Disease (Coronary Atherosclerosis)
07/2020 - 09/2004
6Ischemic Stroke
12/2022 - 04/2015
6Stroke (Strokes)
12/2022 - 01/2014
6Hypoxia (Hypoxemia)
01/2022 - 01/2008
6Carcinoma (Carcinomatosis)
01/2022 - 01/2011
6Fibrosis (Cirrhosis)
09/2021 - 05/2006
6Necrosis
01/2021 - 04/2004
6Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 09/2009
6Neointima
01/2018 - 03/2009
6Atherosclerotic Plaque (Atheroma)
02/2014 - 08/2003
5Ischemia
07/2022 - 09/2005
5Non-alcoholic Fatty Liver Disease
06/2022 - 08/2008
5Unstable Angina
02/2022 - 11/2004
5Colonic Neoplasms (Colon Cancer)
02/2021 - 08/2011
5Vascular System Injuries
01/2021 - 09/2009
5Hypotension (Low Blood Pressure)
03/2020 - 01/2018
5Vascular Diseases (Vascular Disease)
01/2018 - 12/2009
4Thrombosis (Thrombus)
11/2022 - 04/2014
4Neuralgia (Stump Neuralgia)
08/2022 - 01/2018
4Brain Neoplasms (Brain Tumor)
02/2022 - 01/2014
4Coronary Disease (Coronary Heart Disease)
01/2022 - 09/2004
4Heart Failure
01/2022 - 03/2016
4Diabetic Nephropathies (Diabetic Nephropathy)
01/2022 - 11/2004

Drug/Important Bio-Agent (IBA)

45Proteins (Proteins, Gene)FDA Link
08/2022 - 10/2006
20Pharmaceutical PreparationsIBA
03/2022 - 09/2010
19HomocysteineIBA
01/2021 - 03/2002
18Biomarkers (Surrogate Marker)IBA
09/2022 - 08/2008
15Glucose (Dextrose)FDA LinkGeneric
02/2022 - 05/2005
13MicroRNAs (MicroRNA)IBA
08/2022 - 09/2009
12LipidsIBA
01/2022 - 11/2004
12CytokinesIBA
12/2021 - 07/2008
11Apolipoproteins E (ApoE)IBA
11/2022 - 11/2008
11Messenger RNA (mRNA)IBA
09/2022 - 05/2006
11Insulin (Novolin)FDA Link
02/2022 - 01/2003
10LipopolysaccharidesIBA
01/2021 - 04/2005
9EnzymesIBA
01/2022 - 09/2009
9ChemokinesIBA
12/2021 - 08/2002
8Cisplatin (Platino)FDA LinkGeneric
09/2022 - 01/2012
7Tyrosine Kinase InhibitorsIBA
05/2022 - 01/2011
7Calcitonin Gene-Related PeptideIBA
02/2014 - 08/2002
6ErbB Receptors (EGF Receptor)IBA
05/2022 - 01/2011
6RNA (Ribonucleic Acid)IBA
01/2022 - 01/2008
66-methyladenineIBA
01/2022 - 01/2018
6CholesterolIBA
12/2021 - 12/2005
6Phenobarbital (Luminal)FDA Link
01/2021 - 08/2014
6CateninsIBA
01/2020 - 01/2011
6Small Interfering RNA (siRNA)IBA
01/2018 - 08/2010
5Glutamine (L-Glutamine)FDA Link
06/2022 - 06/2017
5InflammasomesIBA
03/2022 - 04/2015
5Therapeutic UsesIBA
02/2022 - 01/2021
5Interleukin-6 (Interleukin 6)IBA
02/2022 - 05/2008
5Blood Glucose (Blood Sugar)IBA
02/2022 - 12/2003
5AntioxidantsIBA
01/2022 - 05/2007
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 05/2008
5Long Noncoding RNAIBA
01/2022 - 01/2019
5Estrogen ReceptorsIBA
01/2021 - 01/2014
5Biological ProductsIBA
01/2021 - 01/2016
5Histone Deacetylase InhibitorsIBA
01/2021 - 08/2011
5Lysine (L-Lysine)FDA Link
01/2021 - 01/2016
5C-Reactive ProteinIBA
05/2020 - 04/2004
5Norepinephrine (Noradrenaline)FDA LinkGeneric
03/2020 - 01/2018
5Phenylephrine (Neo-Synephrine)FDA LinkGeneric
03/2020 - 01/2018
5Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
02/2019 - 08/2003
5Interleukin-8 (Interleukin 8)IBA
12/2017 - 08/2003
5TOR Serine-Threonine KinasesIBA
02/2016 - 03/2013
5CalciumIBA
01/2016 - 07/2008
5Phosphates (Orthophosphate)IBA
10/2015 - 07/2008
5DNA (Deoxyribonucleic Acid)IBA
01/2014 - 12/2003
4ApolipoproteinsIBA
11/2022 - 10/2012
4Antineoplastic Agents (Antineoplastics)IBA
07/2022 - 01/2011
4InterleukinsIBA
02/2022 - 07/2014
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 06/2020

Therapy/Procedure

59Therapeutics
12/2022 - 04/2002
18Drug Therapy (Chemotherapy)
01/2022 - 01/2012
6Percutaneous Coronary Intervention
11/2015 - 11/2004
5Acupuncture Points (Acupuncture Point)
02/2022 - 01/2016
5Spinal Anesthesia
03/2020 - 01/2018
4Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 10/2011